Ceftriaxone-resistant, multidrug-resistant Neisseria gonorrhoeae with a novel mosaic penA-237.001 gene, France, June 2022

We report a ceftriaxone-resistant, multidrug-resistant urogenital gonorrhoea case in a heterosexual woman in France, June 2022. The woman was successfully treated with azithromycin 2?g. She had unprotected sex with her regular partner, who developed urethritis following travel to Vietnam and Switzerland. Whole genome sequencing of the gonococcal isolate (F92) identified MLST ST1901, NG-STAR CC-199, and the novel mosaic penA-237.001, which caused ceftriaxone resistance. penA-237.001 is 98.7% identical to penA-60.001, reported in various ceftriaxone-resistant strains, including the internationally spreading FC428 clone.

Author(s): Berçot Béatrice, Caméléna François, Mérimèche Manel, Jacobsson Susanne, Sbaa Ghalia, Mainardis Mary, Valin Cyrille, Molina Jean-Michel, Bébéar Cécile, Chazelle Emilie, Lot Florence, Golparian Daniel, Unemo Magnus

Publishing year: 2022

Pages: 17-22

In relation to

Our latest news

news

SIBCA 2026: The UrBaCS network presents its solutions for cities and...

news

Physical Activity and Combating a Sedentary Lifestyle: How Does Santé...

news

Etienne Pot Appointed Interim Director General of Santé publique France